EUVIMEDEUVIMED entdecken
Crossref

piSTING: A Pocket‐Independent Agonist Based on Multivalency‐Driven STING Oligomerization

Shao-Hua Zhuo, Tian-Yang Wang, Lang Zhao, Jing-Yun Su, Jin-Jian Hu, Yu-Fen Zhao, Yan-Mei Li iD

Angewandte Chemie International Edition · 2024

DOI: 10.1002/anie.202407037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2024. Verfasst von Shao-Hua Zhuo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Key Lab of Bioorganic Phosphorus Chemistry & Chemical Biology, Tsinghua University, Beijing, 100084, P. R. China. Hauptthemen laut MEDLINE: Membrane Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the National Key R&D Program of China, the Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The stimulator of interferon genes (STING) pathway is a potent therapeutic target for innate immunity. Despite the efforts to develop pocket‐dependent small‐molecule STING agonists that mimic the endogenous STING ligand, cyclic guanosine monophosphate–adenosine monophosphate (cGAMP), most of these agonists showed disappointing results in clinical trials owing to the limitations of the STING pocket. In this study, we developed novel pocket‐independent STING‐activating agonists (piSTINGs), which act through multivalency‐driven oligomerization to activate STING. Additionally, a piSTING‐adjuvanted vaccine elicited a significant antibody response and inhibited tumour growth in therapeutic models. Moreover, a piSTING‐based vaccine combination with aPD‐1 showed remarkable potential to enhance the effectiveness of immune checkpoint blockade (ICB) immunotherapy. In particular, piSTING can strengthen the impact of STING pathway in immunotherapy and accelerate the clinical translation of STING agonists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsHumansAnimalsMiceImmunotherapyNucleotides, CyclicSTING Protein

Stichwörter der Autor:innen

STINGcancer ImmunotherapymultivalencyoligomerizationpiSTING

Substanzen

Membrane ProteinsNucleotides, CyclicSTING1 protein, humanSTING Proteincyclic guanosine monophosphate-adenosine monophosphate

Autor:innen und Institutionen

  • Department of Chemistry, Key Lab of Bioorganic Phosphorus Chemistry & Chemical Biology, Tsinghua University, Beijing, 100084, P. R. China.
  • Institute of Drug Discovery Technology, Ningbo University, Ningbo, 315221, P. R. China.
  • Beijing Institute for Brain Disorders, Beijing, 100069, P. R. China.
  • Center for Synthetic and Systems Biology, Tsinghua University, Beijing, 100084, P. R. China.

ORCID-Profile: Yan-Mei Li

Förderung

  • the National Natural Science Foundation of China
  • the National Key R&D Program of China
  • the Natural Science Foundation of Shandong Province

Zitieren

APA

Zhuo, S. H., Wang, T. Y., Zhao, L., Su, J. Y., Hu, J. J., Zhao, Y. F., & Li, Y. M. (2024). piSTING: A Pocket‐Independent Agonist Based on Multivalency‐Driven STING Oligomerization. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202407037

Vancouver

Zhuo SH, Wang TY, Zhao L, Su JY, Hu JJ, Zhao YF, et al. piSTING: A Pocket‐Independent Agonist Based on Multivalency‐Driven STING Oligomerization. Angewandte Chemie International Edition. 2024. doi:10.1002/anie.202407037

BibTeX
@article{Zhuo2024,
  author = {Zhuo, Shao-Hua and Wang, Tian-Yang and Zhao, Lang and Su, Jing-Yun and Hu, Jin-Jian and Zhao, Yu-Fen and Li, Yan-Mei},
  title = {piSTING: A Pocket‐Independent Agonist Based on Multivalency‐Driven STING Oligomerization},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  doi = {10.1002/anie.202407037}
}
Kostenlos starten →